Reply to "CRISPR screens are feasible in TP53 wild-type cells".

Haapaniemi E, Botla S, Persson J, Schmierer B, Taipale J

Mol. Syst. Biol. 15 (8) e9059 [2019-08-00; online 2019-08-30]

Haapaniemi et al address the issues raised by Brown et al and discuss several differences between the analyses performed by the two groups.

CRISPR Functional Genomics [Collaborative]

PubMed 31464368

DOI 10.15252/msb.20199059

Crossref 10.15252/msb.20199059

pmc: PMC6686827

Publications 9.5.0